Second, elevated haematocrit observed in T2D patients may be mediated via an alleviation of renal stress and glucotoxicity, hence restoration of erythropoietin production; alongside the correction of sympathetic hyperactivity and subsequent prevention of HF [35, 36]. Here, EPO is linked to type 2 diabetes mellitus.